Onkure Therapeutics Releases Q2 2026 Financial Results
AlphaStreet Newsdesk powered by AlphaStreet Intelligence OKUR|EPS -$0.31|Net Loss $15.3M Onkure Therapeutics Inc (OKUR) reported Q2 2026 basic and diluted ...
Monday, September 21, 2026
Tag: Therapeutics
Xilio Therapeutics reports Q1 results (XLO:NASDAQ)
Xilio Therapeutics press release (XLO): Q1 Revenue of $12.6M. Net Loss: Net loss was $9.5 million for the quarter ended March 31, ...
Protagonist Therapeutics Jumps 7.0% in Broad Rally
Riding the sector wave. Protagonist Therapeutics, Inc. (NASDAQ: PTGX) surged 7.0% to $104.39 on Tuesday, April 14, 2026, as a ...
Dogwood Therapeutics, Inc. (DWTX) Q4 2025 Earnings Results
Loss Per Share (GAAP) $0.26 Loss narrows sharply. Dogwood Therapeutics, Inc. (NASDAQ: DWTX) reported a loss of $0.26 per share ...
Trevi Therapeutics, Inc. (TRVI) Q4 2025 Earnings Results
Earnings Per Share (GAAP) $-0.06 vs $-0.10 est. (narrower loss, 37.2%) Loss narrows sharply. Trevi Therapeutics, Inc. (NASDAQ: TRVI) reported ...
Is Crispr Therapeutics (CRSP) The Best Gene-Editing Stock to Buy Now?
Crispr Therapeutics Ag (NASDAQ:CRSP) is one of the Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Biotech company Crispr ...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.